日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Randomized controlled trial of smartphone-based interpretation bias intervention for anxiety and depression

一项关于基于智能手机的解读偏差干预措施治疗焦虑和抑郁症的随机对照试验

Silverman, Alexandra L; Kovarsky Rotta, Gabriela; Shin, Doah; Ferguson, Irelee; Beard, Courtney

Surgical Outcomes of XEN45 Gel Stent Using Ab Interno Technique in Open-Angle Glaucoma: A 2-Year Follow-Up Study

采用内路技术植入XEN45凝胶支架治疗开角型青光眼的手术效果:一项为期2年的随访研究

Kim, Doah; Kim, Myungjin; Lee, Marvin; Rho, Seungsoo

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial

比较含防腐剂和不含防腐剂的溴莫尼定/噻吗洛尔固定复方滴眼液在青光眼患者中的疗效和眼表评估:一项平行组随机试验

Kim, Myungjin; Lee, Chang-Kyu; Shin, Jonghoon; Kim, Doah; Rho, Seungsoo

Criteria for assessing evidence for biomarker-targeted therapies in rare cancers-an extrapolation framework

评估罕见癌症生物标志物靶向治疗证据的标准——外推框架

Cho, Doah; Lord, Sarah J; Ward, Robyn; IJzerman, Maarten; Mitchell, Andrew; Thomas, David M; Cheyne, Saskia; Martin, Andrew; Morton, Rachael L; Simes, John; Lee, Chee Khoon

Clinical characteristics and cytological changes in mucinous obstruction diagnosed by dacryoendoscopy

泪道内镜诊断的黏液性阻塞的临床特征和细胞学变化

Kim, Doah; Lew, Helen

Unraveling the Clinical Features and Outcomes of IgG4-Related Ophthalmic Disease

揭示IgG4相关眼病的临床特征和预后

Kim, Doah; Jeong, SangYoon; Lew, Helen

Sight-Threatening Immune Retinopathy Developing Secondary to Durvalumab Treatment of Small-Cell Lung Cancer: A Case Report

因度伐利尤单抗治疗小细胞肺癌继发威胁视力的免疫性视网膜病变:病例报告

Kim, Doah; Jang, Jeong Kyeong; Sung, Youngje

Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? Illustrating an extrapolation framework

下一代测序,我是否应该对HER2扩增肿瘤使用非适应症抗HER2疗法?举例说明外推框架

Cho, Doah; Lord, Sarah J; Simes, John; Cooper, Wendy; Friedlander, Michael; Bae, Susie; Lee, Chee Khoon

Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidance

将常见癌症的分子靶向治疗证据外推至罕见癌症:方法学指南的范围界定综述

Cho, Doah; Cheyne, Saskia; Lord, Sarah J; Simes, John; Lee, Chee Khoon

Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysis

免疫检查点抑制剂试验中6个月无进展生存率和客观缓解率在估计总生存期中的验证:系统评价和荟萃分析

Kok, Peey-Sei; Cho, Doah; Yoon, Won-Hee; Ritchie, Georgia; Marschner, Ian; Lord, Sally; Friedlander, Michael; Simes, John; Lee, Chee Khoon